No photo of David Blacker

View Scopus Profile

David Blacker

Dr

  • The University of Western Australia (M501), 35 Stirling Highway,

    6009 Perth

    Australia

  • 648 Citations
  • 14 h-Index
20042018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Stroke Medicine & Life Sciences
Middle Cerebral Artery Infarction Medicine & Life Sciences
Arginine Medicine & Life Sciences
Thrombectomy Medicine & Life Sciences
Peptides Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Neuroprotective Agents Medicine & Life Sciences
Decompressive Craniectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2016

Small Project Grant - Pre-clinical Assessment of Poly-arginine Peptides as a Treatment to Reduce Brain Damage Following Stroke

Cross, J., Meloni, B., Knuckey, N. & Blacker, D.

National Stroke Foundation

1/07/15 → 30/06/16

Project: Research

A Randomized Controlled Trial of Cognitive Acceptance & Commitment Therapy (CogACT) for Stroke Survivors Experiencing Cognitive Impairment

Byrnes, M. & Blacker, D.

Neurotrauma Research Program (NRP)

1/01/13 → 31/12/13

Project: Research

Research Output 2004 2018

4 Citations

Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies

Milani, D., Bakeberg, M. C., Cross, J. L., Clark, V. W., Anderton, R. S., Blacker, D. J., Knuckey, N. W. & Meloni, B. P., 1 Mar 2018, In : PLoS One. 13, 3, e0193884.

Research output: Contribution to journal › Article

Open Access
Enantiomers
Middle Cerebral Artery Infarction
enantiomers
toxicity testing
arteries
11 Citations

Assessment of the neuroprotective effects of arginine-rich protamine peptides, poly-arginine peptides (R12-Cyclic, R22) and arginine–tryptophan-containing peptides following in vitro excitotoxicity and/or permanent middle cerebral artery occlusion in rats

Meloni, B. P., Milani, D., Cross, J. L., Clark, V. W., Edwards, A. B., Anderton, R. S., Blacker, D. J. & Knuckey, N. W., Sep 2017, In : NeuroMolecular Medicine. 19, 2-3, p. 271-285 15 p.

Research output: Contribution to journal › Article

Cyclic Peptides
Protamines
Middle Cerebral Artery Infarction
Neuroprotective Agents
Tryptophan
3 Citations

Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat

Milani, D., Cross, J. L., Anderton, R. S., Blacker, D. J., Knuckey, N. W. & Meloni, B. P., 1 Oct 2017, In : Brain Research Bulletin. 135, p. 62-68 7 p.

Research output: Contribution to journal › Article

Middle Cerebral Artery Infarction
Brain Edema
Stroke
Peptides
Jugular Veins
2 Citations

Mechanical thrombectomy for anterior circulation stroke: 5-year experience in a statewide service with differences in pretreatment time metrics across two hospitals sites

Kabra, R., Phillips, T. J., Saw, J. L., Phatouros, C. C., Singh, T. P., Hankey, G. J., Blacker, D., Ghia, D., Prentice, D. & McAuliffe, W., 1 Jun 2017, In : Journal of neurointerventional surgery. 9, 6, p. 535-540 6 p.

Research output: Contribution to journal › Article

Thrombectomy
Stroke
Workflow
Cerebral Infarction
Tertiary Care Centers
14 Citations

Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat

Milani, D., Cross, J. L., Anderton, R. S., Blacker, D. J., Knuckey, N. W. & Meloni, B. P., 1 Jan 2017, In : Neuroscience Research. 114, p. 9-15 7 p.

Research output: Contribution to journal › Article

Middle Cerebral Artery Infarction
Adhesives
Arginine
Peptides
Neuroprotective Agents

Datasets

Photomicrographs of histological sections of kidney and liver tissue.

Milani, D. (Creator), Bakeberg, M. C. (Creator), Cross, J. (Creator), Clark, V. W. (Creator), Anderton, R. (Creator), Blacker, D. (Creator), Knuckey, N. (Creator), Meloni, B. (Creator), Public Library of Science (PLoS), 7 Mar 2018

DOI: 10.1371/journal.pone.0193884.s001

Dataset

Weight loss at 24-hours after permanent MCAO.

Milani, D. (Creator), Bakeberg, M. C. (Creator), Cross, J. (Creator), Clark, V. W. (Creator), Anderton, R. (Creator), Blacker, D. (Creator), Knuckey, N. (Creator), Meloni, B. (Creator), Public Library of Science (PLoS), 7 Mar 2018

DOI: 10.1371/journal.pone.0193884.s002

Dataset